Delivery Order SPE2DB22D2206-SPE2DB24FFJ41
Award Date 1/30/24
Potential Completion Date 1/31/24
Potential Value $1.3K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 1,200,000 units of BICILLIN L-A 2ML. The award has a completion date of February 8, 2024 and a potential value of $1,175.24. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is not associated with any set-aside designation. Amerisourcebergen Drug Corp also holds an indefinite...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 1,200,000 units of BICILLIN L-A, a pharmaceutical product, for $1,175.24. The contract, with a completion date of February 7, 2024, does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) valued...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $1,175.24 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide 1,200,000 units of Bicillin L-A, a pharmaceutical product, with a completion date of February 7, 2024. This delivery order is issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025, which serves as Amerisourcebergen's...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $1,293.49 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 1,200,000 units of BICILLIN L-A 2ML. This delivery order contract has a completion date of February 14, 2024 and was awarded on February 13, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with the DLA that serves as the primary vehicle for the company...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,327.87 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of 1,200,000 units of Bicillin L-A, a penicillin-based antibiotic, by January 31, 2024. Amerisourcebergen Drug Corp is the prime contractor and this award is not associated with any set-aside designation....
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $32,831.46 firm fixed price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical. This award is for the supply of BICILLIN LA 1.2MU 10S, a pharmaceutical product, with a completion date of March 26, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp serves as the prime contractor, providing a range of pharmaceutical products and medical...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 1,200,000 units of 2ml Bicillin L-A, a pharmaceutical product, with a potential value of $1,175.24. This award has a completion date of February 15, 2024 and was made on February 14, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is part of a larger indefinite...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of 1,200,000 units of Bicillin L-A, a prescription antibiotic, to the Defense Logistics Agency (DLA). The $2,102.56 firm-fixed-price delivery order has an ultimate completion date of April 29, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to supply a...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide 1,200,000 units of BICILLIN L-A 2ML, a pharmaceutical product, with a potential value of $2,722.20. The contract has a completion date of January 31, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical and medical products and...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 1,200,000 units of Bicillin L-A, a pharmaceutical product, with a potential value of $1,175.24. The delivery order has a completion date of February 23, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FFJ41Delivery Order
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a delivery order by the Defense Logistics Agency (DLA) to provide 1,200,000 units of BICILLIN L-A, a pharmaceutical product, for a firm fixed price of $1,327.87. The award has a completion date of January 31, 2024. Amerisourcebergen Drug Corp is the prime contractor on an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 and running through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This specific award was not set aside.
Generated 4/30/24, 8:10 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 1/30/24 |